2026-01-20 - Analysis Report
**Financial Report: Procter & Gamble (PG)**

**Company Overview**: Procter & Gamble is an American multinational consumer goods corporation.

**Return Comparison**
- Return rate of review stock (PG): 20.88%
- Return rate of comparison stock (VOO): 93.30%
- Difference in cumulative return: -72.40% (-72.40% divergent from the S&P 500)

**Alpha, Beta Analysis**
```markdown
| Year | CAGR | MDD  | Alpha | Beta | Cap(B) |
|-----|------|------|-------|------|-------|
| 2016-2018 | 4.0% | 10.7% | 0.0% | 0.5 | 215.1B |
| 2017-2019 | 23.0% | 10.7% | 5.0% | 0.5 | 292.3B |
| 2018-2020 | 26.0% | 17.9% | 5.0% | 0.7 | 325.7B |
| 2019-2021 | 39.0% | 17.9% | -5.0% | 0.7 | 382.9B |
| 2020-2022 | 11.0% | 17.9% | 13.0% | 0.6 | 354.7B |
| 2021-2023 | 24.0% | 15.9% | 23.0% | 0.4 | 343.0B |
| 2022-2024 | 7.0% | 15.9% | -12.0% | 0.4 | 392.4B |
| 2023-2025 | -19.0% | 21.6% | -81.0% | 0.2 | 335.4B |
```
**Recent Stock Price Fluctuations**
- Close: $144.53
- Last-market change: -0.07% from $144.63
- 5-day SMA: $144.64
- 20-day SMA: $143.19
- 60-day SMA: $145.72

**RSI, PPO Index Indicators**
- Market Risk Indicator (MRI): 0.80
- RSI: 49.38
- PPO: 0.36
- Hybrid Signal: Buy
- Risk Level: Medium
- Recent relative divergence change: improving (+2.80)
- 7-day Rank change: up (+46)
- 7-day Dynamic Expected Return change: worsening (-3.80%)

**Expected Return**: 0.40%

**Recent News & Significant Events**
```markdown
[2026-01-05] Procter & Gamble (PG) Stock Dips While Market Gains: Key Facts
[2026-01-16] 1 Magnificent S&P 500 Dividend Stock Down 20% to Buy and Hold Forever
[2026-01-19] Wealth Enhancement Advisory Services LLC Raises Stock Holdings in Procter & Gamble Company (The) $PG
[2025-12-16] Jim Cramer identifies his favorite portfolio stock — and it’s not a big tech name
[2026-01-17] Is Procter & Gamble (PG) Offering Value After Recent Share Price Weakness
[2026-01-14] Procter & Gamble CEO could see major wealth boost from stock incentives
```

**Analyst Opinions**
- Analyst Consensus: Buy
- Mean Rating: 2.08
- Opinions: 22
- Target Price: $165.68 / $186.00 / $148.00

**Recent Earnings Analysis**
```markdown
| Date | EPS | Revenue |
|-----|----:|--------|
| 2025-10-24 | 2 | 22.39 B$ |
| 2025-04-24 | 1.58 | 19.78 B$ |
| 2025-01-22 | 1.94 | 21.88 B$ |
| 2024-10-18 | 1.65 | 21.74 B$ |
| 2025-10-24 | 1.65 | 21.74 B$ |
```
**Revenue and Profitability**
```markdown
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $22.39B | 51.37% |
| 2025-06-30 | $20.89B | 49.11% |
| 2025-03-31 | $19.78B | 50.98% |
| 2024-12-31 | $21.88B | 52.39% |
| 2024-09-30 | $21.74B | 52.06% |
```
**Capital and Profitability**
```markdown
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $53.27B | 8.92% |
| 2025-06-30 | $52.01B | 6.95% |
| 2025-03-31 | $52.27B | 7.21% |
| 2024-12-31 | $51.17B | 9.05% |
| 2024-09-30 | $51.84B | 7.64% |
```

**Comprehensive Analysis**
Based on the provided data, Procter & Gamble (PG) has shown a relatively stable return rate compared to the S&P 500 (VOO) with a cumulative return of -72.40% divergent. The company's Alpha, Beta analysis indicates a moderate level of volatility. The recent stock price fluctuations show a slight decline, but the 60-day SMA remains above the current price. The RSI, PPO index indicators suggest a moderate level of risk, and the expected return is 0.40%. The analyst opinions are generally positive, with a mean rating of 2.08 and a target price of $165.68. Overall, the company's revenue and profitability have remained stable, with a profit margin ranging from 49.11% to 52.39%. However, the Equity and ROE have shown a moderate level of fluctuation.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.